PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients

Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors

(2021) Salman M. Toor et al.   Vaccines

Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes

(2021) Wantao Wu et al.   Journal of Hematology & Oncology

Prognostic value of peripheral blood natural killer cells in colorectal cancer

(2020) Yan-ping Tang et al.   BMC GASTROENTEROLOGY

Tissue Determinants of Human NK Cell Development, Function, and Residence

(2020) Pranay Dogra et al.   CELL

Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28

(2020) F.R. Mariotti et al.   BRITISH JOURNAL OF PHARMACOLOGY

PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade

(2020) Marcel P. Trefny et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

TIGIT expression is associated with T-cell suppression and exhaustion and predicts clinical outcome and anti-PD-1 response in follicular lymphoma

(2020) Zhi-Zhang Yang et al.   CLINICAL CANCER RESEARCH

Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer

(2020) Anqi Lin et al.   Frontiers in Immunology

Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome

(2020) Daniëlle Krijgsman et al.   MOLECULAR IMMUNOLOGY

Expression analysis and significance of PD-1, LAG-3 and TIM-3 in human non-small cell lung cancer using spatially-resolved and multiparametric single-cell analysis.

(2019) Ila J Datar et al.   CLINICAL CANCER RESEARCH

Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair–Deficient Colorectal Cancer

(2019) Carino Gurjao et al.   Cancer Immunology Research

Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis

(2019) Bingyan Wang et al.   World Journal of Surgical Oncology

Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients

(2019) Salman M. Toor et al.   Frontiers in Immunology

Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL

(2018) Frank Vari et al.   BLOOD

The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional Approach

(2018) Daniëlle Krijgsman et al.   Frontiers in Immunology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Roles of the immune system in cancer: from tumor initiation to metastatic progression

(2018) Hugo Gonzalez et al.   GENES & DEVELOPMENT

Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy

(2017) Gilles Jobin et al.   GASTROENTEROLOGY

Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization

(2017) Silvia Pesce et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers

(2017) Y Liu et al.   ONCOGENE

Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more

(2017) Laura Chiossone et al.   SEMINARS IN IMMUNOLOGY

Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells

(2016) Toshiko Kamata et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cutting Edge: Programmed Death-1/Programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy

(2014) W.-S. Chang et al.   JOURNAL OF IMMUNOLOGY

Tissue-specific effector functions of innate lymphoid cells

(2013) Niklas K. Björkström et al.   IMMUNOLOGY

PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection

(2013) A. W. MacFarlane et al.   Cancer Immunology Research

Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model

(2011) Kevin Durgan et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Natural Killer Cells: From Basic Research to Treatments

(2011) Eric Vivier et al.   Frontiers in Immunology

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody

(2010) D. M. Benson et al.   BLOOD

Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data

(2010) Cecilia Guastadisegni et al.   EUROPEAN JOURNAL OF CANCER

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

(2010) Kaori Sakuishi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies

(2008) Peter Laszlo Lakatos et al.   WORLD JOURNAL OF GASTROENTEROLOGY